Long Term Outcome of Extracorporeal Membrane Oxygenation Patients in China (ECMO)
Department of Critical Care Medicine, Nanjing Zhong-Da Hospital, Southeast University School of Medicine,China;
Sponsor: Southeast University, China
Listed as NCT03345758, this observational or N/A phase trial focuses on Extracorporeal Membrane Oxygenation and Long-term Outcome and remains ongoing. Sponsored by Southeast University, China, it has been updated 11 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Aug 2024 — Sep 2024 [monthly]
Unknown
Status: Recruiting → Unknown
-
Jul 2024 — Aug 2024 [monthly]
Recruiting
-
Sep 2022 — Jul 2024 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Apr 2022 — Sep 2022 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 6 earlier versions
-
Jan 2021 — Apr 2022 [monthly]
Recruiting
-
Apr 2020 — Jan 2021 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Jan 2020 — Apr 2020 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Jan 2020 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Aug 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Southeast University, China
For direct contact, visit the study record on ClinicalTrials.gov .